Pages that link to "Q33667883"
Jump to navigation
Jump to search
The following pages link to Relevant use of Klotho in FGF19 subfamily signaling system in vivo (Q33667883):
Displaying 50 items.
- Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1 (Q24294403) (← links)
- Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho (Q24306135) (← links)
- Endocrine fibroblast growth factors 15/19 and 21: from feast to famine (Q24629260) (← links)
- Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21) in Vivo (Q24632545) (← links)
- Inventing new medicines: The FGF21 story (Q26823319) (← links)
- Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism (Q26852624) (← links)
- Regulation and function of the FGF23/klotho endocrine pathways (Q26860470) (← links)
- Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease (Q27000415) (← links)
- Exploring mechanisms of FGF signalling through the lens of structural biology (Q27015054) (← links)
- Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice (Q27333726) (← links)
- Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state (Q28070054) (← links)
- Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 (Q28084197) (← links)
- FGF21 requires βklotho to act in vivo (Q28485347) (← links)
- Osteocyte-specific deletion of Fgfr1 suppresses FGF23 (Q28541582) (← links)
- Fundamentals of FGF19 & FGF21 action in vitro and in vivo (Q28729024) (← links)
- Inhibition of Intestinal Bile Acid Transporter Slc10a2 Improves Triglyceride Metabolism and Normalizes Elevated Plasma Glucose Levels in Mice (Q28729212) (← links)
- FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways (Q28741802) (← links)
- Is fibroblast growth factor receptor 4 a suitable target of cancer therapy? (Q33751398) (← links)
- Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats (Q33930333) (← links)
- Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects (Q34034905) (← links)
- Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. (Q34142506) (← links)
- The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. (Q34219880) (← links)
- Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol. (Q34284745) (← links)
- Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved? (Q34572908) (← links)
- Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia (Q34603360) (← links)
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease (Q35020888) (← links)
- Klotho and the Aging Process (Q35033538) (← links)
- Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes (Q35266374) (← links)
- PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels (Q35417067) (← links)
- Molecular basis of Klotho: from gene to function in aging (Q35441666) (← links)
- Membrane and integrative nuclear fibroblastic growth factor receptor (FGFR) regulation of FGF-23 (Q35451269) (← links)
- A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging (Q35537498) (← links)
- Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1. (Q35537540) (← links)
- Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis (Q35836340) (← links)
- βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism (Q36248720) (← links)
- Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites (Q36288312) (← links)
- FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho (Q36415805) (← links)
- Fibroblast growth factor 23 and bone mineralisation (Q36756061) (← links)
- The role of Klotho in energy metabolism (Q36992839) (← links)
- Multiple faces of fibroblast growth factor-23 (Q37312020) (← links)
- Calcium regulates FGF-23 expression in bone (Q37331084) (← links)
- Decline in muscle strength and running endurance in klotho deficient C57BL/6 mice (Q37365630) (← links)
- Concentrations of fetuin-A, osteoprotegerin and α-Klotho in patients with alcoholic liver cirrhosis. (Q37406696) (← links)
- Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice (Q37607946) (← links)
- Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease (Q37781747) (← links)
- Hormone-like fibroblast growth factors and metabolic regulation (Q37866879) (← links)
- Klotho and βKlotho (Q37991255) (← links)
- FGF19 and Cancer (Q37991263) (← links)
- Klotho as a potential biomarker and therapy for acute kidney injury (Q38016065) (← links)
- Role of fibroblast growth factors in elicitation of cell responses (Q38172600) (← links)